Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology
PROTECT
1 other identifier
interventional
150
1 country
1
Brief Summary
This study evaluates whether a drug-free, non-invasive haptic patch (LIBERTY Patch) affects fall-risk classification and balance/mobility confidence in adults ages 55 to 85. Approximately 150 participants are assigned to wear either the active LIBERTY Patch or a visually identical sham patch daily for 7 days. Balance and mobility are assessed using the FallSkip wearable device and a Falls Efficacy Scale questionnaire at baseline and again after 7 days. Neither participants nor investigators know which patch is assigned during the study period, though this can be unblinded in an emergency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2025
CompletedFirst Submitted
Initial submission to the registry
August 19, 2026
CompletedFirst Posted
Study publicly available on registry
August 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
August 24, 2026
August 1, 2026
1.5 years
August 19, 2026
August 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in fall-risk/mobility assessment (FallSkip device)
A 2-3 minute mobility assessment (sit-to-stand, walking, and return to seated position) using the FallSkip wearable device, comparing Active vs. Control groups.
Baseline and Day 7
Change in Falls Efficacy Scale score
A 10-item, self-reported scale (adapted from Tinetti et al., 1990) measuring confidence in performing daily activities (bathing, dressing, walking, transferring, etc.) without falling, scored 1 (very confident) to 10 (not confident at all) per item.
Baseline and Day 7
Secondary Outcomes (1)
Incidence of patch-associated sensations/side effects
Throughout the 7-day study period, assessed at Day 7
Study Arms (2)
Active LIBERTY Patch (Vibrotactile/Haptic)
ACTIVE COMPARATORParticipants apply the active LIBERTY Patch (Haptic Vibrotactile Trigger Technology) daily for 7 days, with fall-risk/mobility assessment (FallSkip device) and Falls Efficacy Scale survey completed at baseline and Day 7.
Control (Sham Patch)
SHAM COMPARATORParticipants apply a visually identical sham patch without active technology daily for 7 days, with the same baseline and Day 7 assessments as the Active arm.
Interventions
A drug-free, non-invasive, investigational topical patch designed to assist with balance and mobility, worn daily for 7 days.
A visually identical patch without active technology, worn daily for 7 days under the same conditions as the active patch.
Eligibility Criteria
You may qualify if:
- Ages 55 to 85, inclusive
- Able to provide written informed consent
- Able to walk independently or with assistive devices
- Lucid, with adequate cognitive ability to consent
You may not qualify if:
- History of severe neurological disorders (e.g., advanced Parkinson's, severe stroke history)
- Known allergies to adhesives
- Currently hospitalized
- Use of drugs of abuse (illicit or prescription)
- Severe visual/auditory impairments affecting gait or balance
- Terminal illness or life expectancy less than 6 months
- Severe dementia or cognitive impairment preventing consent
- Ongoing physical therapy specifically targeting balance/gait
- Post-stroke
- Pregnant
- Existing or planned implantation of a pacemaker or other electrical device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SuperPatch Limited LLClead
- Clarity Science LLCcollaborator
Study Sites (1)
Anna Toker, MD
Mansfield, Texas, 76063, United States
Related Publications (2)
Fason J, Hurwitz P, Gudin J. Reducing Pain and Improving Mobility Using Haptic Patch Technology: Results of the RESTORE Study. Pain Ther. 2025 Dec;14(6):1797-1807. doi: 10.1007/s40122-025-00780-0. Epub 2025 Oct 8.
PMID: 41057672BACKGROUNDTinetti ME, Richman D, Powell L. Falls efficacy as a measure of fear of falling. J Gerontol. 1990 Nov;45(6):P239-43. doi: 10.1093/geronj/45.6.p239.
PMID: 2229948BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Participants and investigators are masked to patch assignment (active LIBERTY Patch vs. visually identical sham patch) throughout the 7-day study period.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2026
First Posted
August 24, 2026
Study Start
June 16, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
August 24, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. This is a minimal-additional-risk, single-site-network study in an at-risk elderly population (ages 55-85) evaluating an investigational, non-significant-risk device, conducted under a HIPAA Authorization and Advarra IRB oversight. Participant health data are used and disclosed only to the parties specified in the informed consent (the sponsor, Clarity Science, LLC, Advarra IRB, and applicable regulatory authorities) for purposes of conducting this study. Given the population's potential vulnerability (older adults, some with mobility impairment) and the narrow consented scope of data use, de-identified data sharing beyond these parties was not part of the consent framework, consistent with the study's HIPAA Authorization.